Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics

Abstract

Addictive diseases, including addiction to heroin, prescription opioids, or cocaine, pose massive personal and public health costs. Addictions are chronic relapsing diseases of the brain caused by drug-induced direct effects and persisting neuroadaptations at the epigenetic, mRNA, neuropeptide, neurotransmitter, or protein levels. These neuroadaptations, which can be specific to drug type, and their resultant behaviors are modified by various internal and external environmental factors, including stress responsivity, addict mindset, and social setting. Specific gene variants, including variants encoding pharmacological target proteins or genes mediating neuroadaptations, also modify vulnerability at particular stages of addiction. Greater understanding of these interacting factors through laboratory-based and translational studies have the potential to optimize early interventions for the therapy of chronic addictive diseases and to reduce the burden of relapse. Here, we review the molecular neurobiology and genetics of opiate addiction, including heroin and prescription opioids, and cocaine addiction.

Individualizing Opioid Use Disorder (OUD) Treatment: Time to Fully Embrace a Chronic Disease Model

“…Staying abreast of emerging data will provide better understanding on how to manage patients with substance use disorder. Our knowledge of the genetics underlying predisposition to addiction [6][7][8], alterations in neurotransmitter tone [38,39], and how reward deficiency is contributing to stress and relapse [40] will supply us with a more sophisticated and heuristically useful view of the patient's physiological condition and allow for a more individualized approach.…”

Advancing Service Integration in Opioid Treatment Progams for the Care and Treatment of Hepatitis C Infection

“…Research studies have clearly shown that addiction to drugs of abuse is a brain disease, and if left untreated, progresses to chronic debilitating outcomes with associated medical and psychiatric comorbidities [2]. Therefore, opioid dependent individuals may manifest complex medical and social problems that require both substantial medical care and the medical management of substance abuse.…”

Opiate addiction - current trends and treatment options

“…Such a counter-regulatory action by the KOP-r/dynorphin system may therefore mediate, in part, the negatively reinforcing aspects of withdrawal from drugs of abuse and may exacerbate the chronic relapsing nature of addictive diseases. 25 The euphoria and abuse liability caused by opiates is related to its rewarding and reinforcing effects on brain because of its rapid entry. This is apparent in the transition from oral or intranasal to smoked or I.V routes in order to achieve immediate absorption.…”